Concerns growing over Pfizer’s tactics to advance into generic market

Published: 2012-01-30 06:59:00

Updated: 2012-01-30 06:59:00

Controversial tactics that Pfizer Korea is using to protect its revenue through selling of seven generic drugs could become a model for the domestic pharmaceutical industry as more multinational companies lose exclusive rights to distribute their most valuable medicines, according to industry off...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK